Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

AstraZeneca AZ

AZ takes Chi-Med’s kidney cancer drug into phase III

SAVOIR trial will compare Chi-Med’s savolitinib to Pfizer’s Sutent

- PMLiVE

Novartis gets first-line approval for Xalkori challenger in EU

Zykadia showed a 45% reduction in the risk of disease progression compared to chemo

- PMLiVE

Dr Bug mobile game introduces kids to antibiotics, bacteria and viruses

The not-for-profit app is a collaboration between Oxford PharmaGenesis and Global Initiative

- PMLiVE

Purdue Pharma appoints Dr Craig Landau as its CEO

He also takes up president role

- PMLiVE

Digital disruption in market access

Infinite possibilities

- PMLiVE

Onyx Health wins OLM Diagnostics account

Will develop a marketing strategy for the UK-based firm

- PMLiVE

New Merck Foundation appoints Rasha Kelej

She takes up role as CEO of the pharma firm's newly-established non-profit

- PMLiVE

Merck & Co’s anacetrapib rescued by positive phase III trial

Data suggests drug reduces MACE compared to placebo

- PMLiVE

GSK starts trial of Nucala to seek alternate indications

Asthma therapy drug to be used to target severe nasal polyposis

- PMLiVE

Delivering ‘accountable marketing’

It’s about time… and data

- PMLiVE

Mobile health and patient outcomes

Putting the humanity back into patient care

Sanofi reception

Sanofi and Regeneron bag EU approval for arthritis drug Kevzara

The IL-6 inhibitor will be used in combination with methotrexate for adults with RA

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links